Back
Rhythm Pharmaceuticals Stock Price Chart

Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
RYTM
Rhythm Pharmaceuticals
Last Price:
$51.98
Seasonality Move:
-9.14%
7 Day Trial
ALL ACCESS PASS
$
7

Meet the Founder That's Revolutionizing Smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RYTM is experiencing slight buying pressure.
Rhythm Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 52.08 | Buy |
20-day SMA: | 53.09 | Buy |
50-day SMA: | 55.83 | Sell |
200-day SMA: | 51.44 | Buy |
8-day EMA: | 52.93 | Buy |
20-day EMA: | 53.42 | Buy |
50-day EMA: | 54.88 | Sell |
200-day EMA: | 51.41 | Buy |
Rhythm Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.94 | Sell |
Relative Strength Index (14 RSI): | 51.99 | Buy |
Chaikin Money Flow: | 63513 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (51.29 - 56.61) | Buy |
Bollinger Bands (100): | (52.4 - 60.4) | Sell |
Rhythm Pharmaceuticals Technical Analysis
Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Rhythm Pharmaceuticals Stock
Is Rhythm Pharmaceuticals Stock a Buy?
-
Rhythm Pharmaceuticals share price is 54.23 while RYTM 8-day simple moving average is 52.08, which is a Buy signal.
-
The stock price of RYTM is 54.23 while Rhythm Pharmaceuticals 20-day SMA is 53.09, which makes it a Buy.
-
Rhythm Pharmaceuticals 50-day simple moving average is 55.83 while RYTM share price is 54.23, making it a Sell technically.
-
RYTM stock price is 54.23 and Rhythm Pharmaceuticals 200-day simple moving average is 51.44, creating a Buy signal.
RYTM Technical Analysis vs Fundamental Analysis
Sell
46
Rhythm Pharmaceuticals (RYTM)
is a Sell
Is Rhythm Pharmaceuticals a Buy or a Sell?
-
Rhythm Pharmaceuticals stock is rated a SellThe current Rhythm Pharmaceuticals [RYTM] share price is $54.23. The Score for RYTM is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Rhythm Pharmaceuticals Stock Info
Market Cap:
3.4B
Price in USD:
54.23
Share Volume:
479.2K
Rhythm Pharmaceuticals 52-Week Range
52-Week High:
68.58
52-Week Low:
35.17
Sell
46
Rhythm Pharmaceuticals (RYTM)
is a Sell
Rhythm Pharmaceuticals Share Price Forecast
-
What is the Rhythm Pharmaceuticals stock price today?The Rhythm Pharmaceuticals stock price is 54.23 USD today.
-
Will RYTM stock go up or go down?Rhythm Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Rhythm Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rhythm Pharmaceuticals is overvalued.
Is Rhythm Pharmaceuticals Stock a Buy?
-
Rhythm Pharmaceuticals share price is 54.23 while RYTM 8-day exponential moving average is 52.93, which is a Buy signal.
-
The stock price of RYTM is 54.23 while Rhythm Pharmaceuticals 20-day EMA is 53.42, which makes it a Buy.
-
Rhythm Pharmaceuticals 50-day exponential moving average is 54.88 while RYTM share price is 54.23, making it a Sell technically.
-
RYTM stock price is 54.23 and Rhythm Pharmaceuticals 200-day simple moving average is 51.41, creating a Buy signal.
Fundamental Analysis of Rhythm Pharmaceuticals
Is Rhythm Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.27 per share, an increase next quarter of $0.09 per share, an increase this year of $1.64 per share, and an increase next year of $1.20 per share.
Technical Analysis of Rhythm Pharmaceuticals
Should I short Rhythm Pharmaceuticals stock?
-
RYTM Moving Average Covergence Divergence (MACD) indicator is -0.94, suggesting Rhythm Pharmaceuticals is a Sell
-
Rhythm Pharmaceuticals Relative Strength Index (RSI) is 51.99, which suggest Rhythm Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Rhythm Pharmaceuticals is (51.29 - 56.61), which suggest Rhythm Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Rhythm Pharmaceuticals is (52.4 - 60.4), which suggest Rhythm Pharmaceuticals is a Sell
* Rhythm Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.